| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 67.718 | 152.134 | 256.646 | 290.923 |
| Total Income - EUR | - | - | - | - | - | - | 67.965 | 152.134 | 256.660 | 290.923 |
| Total Expenses - EUR | - | - | - | - | - | - | 66.820 | 113.478 | 181.408 | 237.417 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 1.144 | 38.656 | 75.252 | 53.507 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 604 | 37.296 | 73.068 | 42.184 |
| Employees | - | - | - | - | - | - | 2 | 2 | 3 | 3 |
Check the financial reports for the company - Eye Focus Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 5.992 | 86.433 | 69.305 | 56.883 |
| Current Assets | - | - | - | - | - | - | 26.888 | 43.722 | 114.565 | 118.317 |
| Inventories | - | - | - | - | - | - | 24.837 | 28.762 | 50.823 | 39.845 |
| Receivables | - | - | - | - | - | - | 0 | 6.061 | 8.917 | 18.426 |
| Cash | - | - | - | - | - | - | 2.052 | 8.899 | 54.825 | 60.046 |
| Shareholders Funds | - | - | - | - | - | - | 645 | 37.942 | 108.258 | 118.153 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 32.236 | 92.213 | 75.613 | 57.047 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4774 - 4774" | |||||||||
| CAEN Financial Year |
4774
|
|||||||||
Comments - Eye Focus Med S.r.l.